产品名称 | NebuSelect™ Recombinant Cynomolgus Oncostatin M/OSM, His-tag |
---|---|
目录号 | NBL-241293 |
别名 | Oncostatin M/OSM |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | XP_045219762.1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241293-100ug | 100ug | Inquire | Inquire | |
NBL-241293-1mg | 1mg | Inquire | Inquire | |
NBL-241293-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus Oncostatin M/OSM, His-tag
Catalog#:
NBL-241293
Description:
NebuSelect™ Recombinant Cynomolgus Oncostatin M/OSM, His-tag(Cat#NBL-241293) is expressed in HEK293 with His tag at the C-terminus.It contains Ala27-Arg221.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 23.31 kDa. Due to glycosylation, the protein migrates to 27-50 kDa based on Bis-Tris PAGE result.
Target Name:
Oncostatin M/OSM
Target Information:
OSM is a pleiotropic cytokine that initiates its biological activities by binding to specific cell surface receptors. Inhibits the proliferation of a number of tumor cell lines. Stimulates proliferation of AIDS-KS cells. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells. Uses both type I OSM receptor (heterodimers composed of LIFR and IL6ST) and type II OSM receptor (heterodimers composed of OSMR and IL6ST). Involved in the maturation of fetal hepatocytes, thereby promoting liver development and regeneration.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.